Appointment of Francis Van Parys as CEO

Summary by AI BETAClose X

Oxford Nanopore Technologies plc announced the appointment of Francis Van Parys as Chief Executive Officer, effective March 2, 2026, succeeding Gordon Sanghera who will transition to an advisory role until early 2027. Van Parys brings over 20 years of experience leading multi-billion-dollar life science businesses, including his current role as President and CEO of Radiometer, and previously held senior positions at Cytiva and GE Healthcare. The company highlighted Van Parys's expertise in scaling innovation-driven organizations and his deep regulatory knowledge as key assets for the company's next growth phase.

Disclaimer*

UK 100

Latest directors dealings